JP2015145398A - (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 - Google Patents
(+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 Download PDFInfo
- Publication number
- JP2015145398A JP2015145398A JP2015066151A JP2015066151A JP2015145398A JP 2015145398 A JP2015145398 A JP 2015145398A JP 2015066151 A JP2015066151 A JP 2015066151A JP 2015066151 A JP2015066151 A JP 2015066151A JP 2015145398 A JP2015145398 A JP 2015145398A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- base
- potassium
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AYVHIUIIRXDSCH-VFWDIBGWSA-N C[C@H]([C@@H]1CNC2)[C@]12c(cc1Cl)ccc1Cl Chemical compound C[C@H]([C@@H]1CNC2)[C@]12c(cc1Cl)ccc1Cl AYVHIUIIRXDSCH-VFWDIBGWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/20—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/38—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
本発明は、(+)-1-(3,4-ジクロロフェニル)-3-アザビシクロ[3.1.0]ヘキサンまたはその薬学的に許容される塩、ならびに(−)-1-(3,4-ジクロロフェニル)-3-アザビシクロ[3.1.0]ヘキサンまたはその薬学的に許容される塩の調製のための方法に関する。これらの化合物は、例えば、うつ病、不安障害、摂食障害および尿失禁の治療に有用であることが公知である(米国特許第6,372,919号(特許文献1)、同第6,569,887号(特許文献2)、および同第6,716,868号(特許文献3)を参照)。
本発明は、下記式 I:
の化合物、またはその薬学的に許容される塩を調製するための方法であって、以下の工程を含む方法に関する:
塩基の存在下、下記式:
の3,4-ジクロロフェニルアセトニトリルと(S)-エピクロロヒドリンとを接触させて、下記式 II:
のシクロプロピル化合物を得る工程;次いで
該式 II の化合物を還元剤で還元して、下記式 III:
のアミノアルコール化合物を得る工程;次いで
該式 III の化合物を塩素化剤で塩素化して、下記式 IV:
のクロロ化合物を得る工程;次いで
該式 IV の化合物を塩基で脱水環化して、式 I の化合物、またはその薬学的に許容される塩を得る工程。
の化合物またはその薬学的に許容される塩を調製するための方法であって、以下の工程を含む方法に関する:
下記式 IV-1:
の化合物を塩基で脱水環化して、式 I の化合物、またはその薬学的に許容される塩を得る工程。
の化合物、またはその薬学的に許容される塩を調製するための方法であって、以下の工程を含む方法に関する:
塩基の存在下、下記式:
の3,4-ジクロロフェニルアセトニトリルと(R)-エピクロロヒドリンとを接触させて、下記式 IIb:
のシクロプロピル化合物を得る工程;次いで
該式 IIb の化合物を還元剤で還元して、下記式 IIIb:
のアミノアルコール化合物を得る工程;次いで
該式 IIIb の化合物を塩素化剤で塩素化して、下記式 IVb:
のクロロ化合物を得る工程;次いで
該式 IVb の化合物を塩基で脱水環化して、式 Ib の化合物、またはその薬学的に許容される塩を得る工程。
の化合物、またはその薬学的に許容される塩を調製するための方法であって、以下の工程を含む方法に関する:
下記式 IVb-2:
の化合物を塩基で脱水環化して、式 Ib の化合物、またはその薬学的に許容される塩を得る工程。
(1R,5S)-(+)-1-(3,4-ジクロロフェニル)-3-アザビシクロ[3.10]ヘキサン
N2雰囲気下、-15℃で、3,4-ジクロロフェニルアセトニトリル(3.50 kg)およびS-(+)-エピクロロヒドリン(2.22 kg)のTHF(18.5 L)溶液に、NaHMDS(16.5 L, THF中2M)を3時間かけて滴下した。反応混合物を-15℃で3時間攪拌し、次いで-5℃で終夜攪拌した。BH3-Me2S(正味, 10M, 4.4 L)を2時間かけて添加した。次いで、反応混合物を3時間かけて徐々に40℃に温めた。40℃で1.5時間熟成した後、反応混合物を20〜25℃に冷却し、2N HCl溶液(27.7 L)中でゆっくりと失活させた。次いで、失活させた混合物を40℃で1時間熟成した。濃NH4OH(6.3 L)を添加して、水層を捨てた。i-PrOAc(18.5 L)および5%第二リン酸ナトリウム(18.5 L)を加えた。次いで、有機相を飽和食塩水(18.5 L)で洗浄し、真空下で、共沸乾燥して、溶媒をi-PrOAc(約24.5 L)に置換した。
Claims (13)
- 塩基の存在下、3,4-ジクロロフェニルアセトニトリルと(S)-エピクロロヒドリンとを接触させて、式 II のシクロプロピル化合物を得る工程で、該塩基が、ナトリウムヘキサメチルジシラジド(NaHMDS)、カリウムヘキサメチルジシラジド(KHMDS)、リチウムヘキサメチルジシラジド(LiHMDS)、カリウムt-ブトキシド、カリウムt-ペントキシド、カリウムアミラート、リチウムジイソプロピルアミド(LDA)、リチウムテトラメチルピペリジド(LiTMP)、sec-ブチルリチウム、およびtert-ブチルリチウムより選択される、請求項1記載の方法。
- 塩基が、ナトリウムヘキサメチルジシラジド(NaHMDS)、カリウムヘキサメチルジシラジド(KHMDS)およびリチウムヘキサメチルジシラジド(LiHMDS)より選択される、請求項3記載の方法。
- 塩基がナトリウムヘキサメチルジシラジド(NaHMDS)である、請求項4記載の方法。
- 式 II の化合物を還元剤で還元して、式 III のアミノアルコール化合物を得る工程で、該還元剤が、ボランジメチルスルフィド錯体、ボランテトラヒドロフラン錯体、水素化ほう素ナトリウム‐三ふっ化ほう素エーテラート、ジアルキルボラン、9-ボラビシクロ[3.3.1]ノナン(9-BBN)、および水素化リチウムアルミニウム(LAH)より選択される、請求項1記載の方法。
- 還元剤がボランジメチルスルフィド錯体である、請求項6記載の方法。
- 式 III の化合物を塩素化剤で塩素化して、式 IV のクロロ化合物を得る工程で、該塩素化剤が、塩化チオニル、SO2Cl2、およびPh3P/CCl4より選択される、請求項1記載の方法。
- 塩素化剤が塩化チオニルである、請求項8記載の方法。
- 式 IV の化合物を塩基で脱水環化して、式 I の化合物を得る工程で、該塩基が、水酸化ナトリウム、水酸化カリウム、炭酸水素カリウム、炭酸水素ナトリウム、炭酸カリウム、炭酸ナトリウム、Et3N、i-Pr2NEt、DABCOおよびDBUより選択される、請求項1記載の方法。
- 塩基が水酸化ナトリウムである、請求項10記載の方法。
- 工程が中間体化合物を単離せずに連続して行われる、請求項1記載の方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79609706P | 2006-04-28 | 2006-04-28 | |
US60/796,097 | 2006-04-28 | ||
US11/740,667 | 2007-04-26 | ||
US11/740,667 US20080045725A1 (en) | 2006-04-28 | 2007-04-26 | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013181165A Division JP5802718B2 (ja) | 2006-04-28 | 2013-09-02 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016104293A Division JP2016155863A (ja) | 2006-04-28 | 2016-05-25 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015145398A true JP2015145398A (ja) | 2015-08-13 |
JP5984988B2 JP5984988B2 (ja) | 2016-09-06 |
Family
ID=38655840
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009521739A Withdrawn JP2010500972A (ja) | 2006-04-28 | 2007-04-27 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
JP2013181165A Expired - Fee Related JP5802718B2 (ja) | 2006-04-28 | 2013-09-02 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
JP2015066151A Active JP5984988B2 (ja) | 2006-04-28 | 2015-03-27 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
JP2016104293A Pending JP2016155863A (ja) | 2006-04-28 | 2016-05-25 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009521739A Withdrawn JP2010500972A (ja) | 2006-04-28 | 2007-04-27 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
JP2013181165A Expired - Fee Related JP5802718B2 (ja) | 2006-04-28 | 2013-09-02 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016104293A Pending JP2016155863A (ja) | 2006-04-28 | 2016-05-25 | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Country Status (16)
Country | Link |
---|---|
US (7) | US20080045725A1 (ja) |
EP (2) | EP2012777A2 (ja) |
JP (4) | JP2010500972A (ja) |
KR (1) | KR101437038B1 (ja) |
CN (1) | CN101573034B (ja) |
AT (1) | ATE550322T1 (ja) |
AU (1) | AU2007288444B8 (ja) |
BR (1) | BRPI0710882A2 (ja) |
CA (1) | CA2650658C (ja) |
ES (1) | ES2387214T3 (ja) |
HK (1) | HK1127899A1 (ja) |
IL (1) | IL194750A (ja) |
MX (1) | MX2008013801A (ja) |
NZ (1) | NZ572247A (ja) |
RU (1) | RU2008146964A (ja) |
WO (2) | WO2007127396A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
WO2007127421A2 (en) * | 2006-04-28 | 2007-11-08 | Merck & Co., Inc. | Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes |
JP2016535796A (ja) * | 2013-11-11 | 2016-11-17 | ユーシミクス・バイオサイエンス・インコーポレイテッドEuthymics Bioscience,Inc. | 新規な方法 |
WO2023034293A1 (en) | 2021-08-31 | 2023-03-09 | Ethismos Research, Inc. | Methods of preventing and treating pain and associated symptoms |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4131611A (en) * | 1975-07-31 | 1978-12-26 | American Cyanamid Company | Azabicyclohexanes |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
WO2006023659A2 (en) * | 2004-08-18 | 2006-03-02 | Dov Pharmaceutical, Inc. | Novel polymorphs of azabicyclohexane |
JP5802718B2 (ja) * | 2006-04-28 | 2015-10-28 | ユーシミクス バイオサイエンス インコーポレイテッド | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS175641B1 (en) * | 1973-06-14 | 1977-05-31 | Boris D Babickij | Making method of 2-alkyl-1,3-butadiene's 1,4-transpolymers and/or 2-alkyl-1,3-butadiene's stereoregular 1,4 trans-copolymers with 1,3-butadiene |
JPS535994B2 (ja) * | 1974-09-26 | 1978-03-03 | ||
US4088652A (en) * | 1975-07-31 | 1978-05-09 | American Cyanamid Company | Acylazabicyclohexanes |
US4231935A (en) * | 1975-07-31 | 1980-11-04 | American Cyanamid Company | 1-Phenyl-3-azabicyclo[3.1.0]hexanes |
US4196120A (en) * | 1975-07-31 | 1980-04-01 | American Cyanamid Company | Azabicyclohexanes, method of use and preparation of the same |
GB1532682A (en) * | 1976-04-27 | 1978-11-22 | Bristol Myers Co | Process for the preparation of cephadroxil |
GR72713B (ja) | 1976-09-15 | 1983-12-01 | American Cyanamid Co | |
US4118393A (en) * | 1977-06-23 | 1978-10-03 | American Cyanamid Company | Phenyl azabicyclohexanones |
US4118417A (en) * | 1977-06-23 | 1978-10-03 | American Cyanamid Company | Process for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acids |
IL65843A (en) | 1977-08-11 | 1986-12-31 | American Cyanamid Co | Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type |
CH644580A5 (de) * | 1980-01-29 | 1984-08-15 | Hoffmann La Roche | Cyclohexen-derivate. |
IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
JPS58150526A (ja) * | 1982-03-04 | 1983-09-07 | Ube Ind Ltd | 光学活性プロパルギルアルコ−ル類およびその製法 |
DE3324263A1 (de) * | 1983-07-06 | 1985-01-17 | Hoechst Ag, 6230 Frankfurt | Derivate der 2-azabicyclo(3.1.0)hexan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-azabicyclo(3.1.0)hexan-derivate als zwischenprodukte und verfahren zu deren herstellung |
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
US5198459A (en) * | 1987-07-11 | 1993-03-30 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
US5075341A (en) * | 1989-12-01 | 1991-12-24 | The Mclean Hospital Corporation | Treatment for cocaine abuse |
FI910897A (fi) | 1990-02-28 | 1991-08-29 | Lilly Co Eli | Foerbaettringar roerande (s)-norfluoxetin. |
US5130430A (en) * | 1990-10-31 | 1992-07-14 | Neurogen Corporation | 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands |
US6204284B1 (en) * | 1991-12-20 | 2001-03-20 | American Cyanamid Company | Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5232934A (en) * | 1992-07-17 | 1993-08-03 | Warner-Lambert Co. | Method for the treatment of psychomotor stimulant addiction |
US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
US5556837A (en) * | 1994-08-01 | 1996-09-17 | Regeneron Pharmaceuticals Inc. | Methods for treating addictive disorders |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
US5762925A (en) * | 1994-11-03 | 1998-06-09 | Sagen; Jacqueline | Preventing opiate tolerance by cellular implantation |
DE69616808T2 (de) * | 1995-07-17 | 2002-05-29 | Warner Lambert Co | Kristallines (r-(r*,r*))-2-(4-fluorphenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrol-1-heptancarbonsäure hemi calcium salz (atorvastatin) |
AU702594B2 (en) | 1995-10-13 | 1999-02-25 | Duphar International Research B.V. | Process for the preparation of enantiomerically pure imidazolyl compounds |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
ZA969485B (en) * | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
US6423704B2 (en) * | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
TW513409B (en) * | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
US5911992A (en) * | 1997-06-12 | 1999-06-15 | A. Glenn Braswell | Method for controlling weight with hypericum perforatum and garcinia cambogia |
US6121261A (en) * | 1997-11-19 | 2000-09-19 | Merck & Co., Inc. | Method for treating attention deficit disorder |
DE69822218T2 (de) * | 1997-12-05 | 2005-02-03 | Eisai Co., Ltd. | Donepezil polykristalle und verfharen zu ihrer herstellung |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
US20030013740A1 (en) | 1998-03-27 | 2003-01-16 | Martin P. Redmon | Stable dosage forms of fluoxetine and its enantiomers |
JP4194715B2 (ja) | 1998-08-31 | 2008-12-10 | 大正製薬株式会社 | 6−フルオロビシクロ[3.1.0]ヘキサン誘導体 |
DK1110943T3 (da) | 1998-08-31 | 2004-10-11 | Taisho Pharmaceutical Co Ltd | 6-fluorbicyclo[3.1.0]hexanderivater |
JP2000159761A (ja) | 1998-11-30 | 2000-06-13 | Yoshio Takeuchi | フルオロサリドマイド |
JP4290265B2 (ja) | 1999-03-02 | 2009-07-01 | 第一ファインケミカル株式会社 | 新規な不斉配位子 |
US6109269A (en) * | 1999-04-30 | 2000-08-29 | Medtronic, Inc. | Method of treating addiction by brain infusion |
EP1211253B1 (en) * | 1999-08-20 | 2004-10-13 | Takeda Chemical Industries, Ltd. | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
US20060173064A1 (en) | 2001-08-24 | 2006-08-03 | Lippa Arnold S | (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
ES2312637T3 (es) | 2001-12-04 | 2009-03-01 | Schering Corporation | Derivados de n-aril-n`-arilcicloalquil-urea como antagonistas de mch para el tratamiento de la obesidad. |
US20040127541A1 (en) * | 2002-07-31 | 2004-07-01 | Janet Codd | Bicifadine formulation |
US20080027119A1 (en) | 2002-07-31 | 2008-01-31 | Lippa Arnold S | Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders |
BR0315433A (pt) * | 2002-11-08 | 2005-08-30 | Dov Pharmaceutical Inc | Polimorfos de cloridreto de bicifadine |
CN1894206A (zh) * | 2003-12-15 | 2007-01-10 | 日本烟草产业株式会社 | N-取代的n-磺酰氨基环丙烷化合物和其药学应用 |
SI1745040T1 (sl) | 2004-02-23 | 2010-04-30 | Venue Glaxo Group Ltd | Derivati azabiciklo(3.1.0)heksana, uporabni kot modulatorji dopaminskih receptorjev d3 |
US20060100263A1 (en) | 2004-11-05 | 2006-05-11 | Anthony Basile | Antipyretic compositions and methods |
EP1874298A4 (en) * | 2005-03-08 | 2009-08-05 | Dov Pharmaceutical Inc | METHOD AND COMPOSITIONS FOR THE PREPARATION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO [3,1,0] HEXANES |
EP1879578A4 (en) | 2005-03-21 | 2009-05-13 | Dov Pharmaceutical Inc | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE |
GB0507602D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
AU2006275870B2 (en) * | 2005-07-27 | 2013-01-10 | Otsuka America Pharmaceutical, Inc. | Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
WO2007022933A1 (en) | 2005-08-22 | 2007-03-01 | Glaxo Group Limited | Triazole derivatives as modulators of dopamine d3 receptors |
GB0517193D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
WO2007127421A2 (en) | 2006-04-28 | 2007-11-08 | Merck & Co., Inc. | Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes |
US8138377B2 (en) * | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
US20080269348A1 (en) * | 2006-11-07 | 2008-10-30 | Phil Skolnick | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use |
KR100837555B1 (ko) * | 2006-11-24 | 2008-06-12 | 동부일렉트로닉스 주식회사 | 반도체 소자 및 그 제조 방법 |
US8002193B2 (en) * | 2007-03-12 | 2011-08-23 | Visa U.S.A. Inc. | Payment card dynamically receiving power from external source |
-
2007
- 2007-04-26 US US11/740,667 patent/US20080045725A1/en not_active Abandoned
- 2007-04-27 WO PCT/US2007/010288 patent/WO2007127396A1/en active Application Filing
- 2007-04-27 AT AT07776380T patent/ATE550322T1/de active
- 2007-04-27 ES ES07776380T patent/ES2387214T3/es active Active
- 2007-04-27 CN CN200780015012XA patent/CN101573034B/zh active Active
- 2007-04-27 JP JP2009521739A patent/JP2010500972A/ja not_active Withdrawn
- 2007-04-27 CA CA2650658A patent/CA2650658C/en not_active Expired - Fee Related
- 2007-04-27 EP EP07835762A patent/EP2012777A2/en active Pending
- 2007-04-27 RU RU2008146964/04A patent/RU2008146964A/ru not_active Application Discontinuation
- 2007-04-27 KR KR1020087029108A patent/KR101437038B1/ko not_active IP Right Cessation
- 2007-04-27 BR BRPI0710882-6A patent/BRPI0710882A2/pt not_active IP Right Cessation
- 2007-04-27 NZ NZ572247A patent/NZ572247A/en not_active IP Right Cessation
- 2007-04-27 MX MX2008013801A patent/MX2008013801A/es active IP Right Grant
- 2007-04-27 WO PCT/US2007/011669 patent/WO2008024143A2/en active Application Filing
- 2007-04-27 EP EP07776380A patent/EP2061318B1/en not_active Not-in-force
- 2007-04-27 AU AU2007288444A patent/AU2007288444B8/en not_active Ceased
-
2008
- 2008-10-22 IL IL194750A patent/IL194750A/en active IP Right Grant
-
2009
- 2009-06-12 HK HK09105289.0A patent/HK1127899A1/xx not_active IP Right Cessation
-
2010
- 2010-05-18 US US12/782,705 patent/US20100298574A1/en not_active Abandoned
-
2011
- 2011-08-10 US US13/207,279 patent/US20110295020A1/en not_active Abandoned
-
2012
- 2012-02-03 US US13/366,211 patent/US20120142940A1/en not_active Abandoned
-
2013
- 2013-07-18 US US13/945,605 patent/US9527813B2/en active Active
- 2013-09-02 JP JP2013181165A patent/JP5802718B2/ja not_active Expired - Fee Related
-
2015
- 2015-03-27 JP JP2015066151A patent/JP5984988B2/ja active Active
-
2016
- 2016-05-25 JP JP2016104293A patent/JP2016155863A/ja active Pending
- 2016-12-02 US US15/367,718 patent/US20170233333A1/en not_active Abandoned
-
2017
- 2017-11-22 US US15/820,959 patent/US20180319738A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4131611A (en) * | 1975-07-31 | 1978-12-26 | American Cyanamid Company | Azabicyclohexanes |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
WO2006023659A2 (en) * | 2004-08-18 | 2006-03-02 | Dov Pharmaceutical, Inc. | Novel polymorphs of azabicyclohexane |
JP5802718B2 (ja) * | 2006-04-28 | 2015-10-28 | ユーシミクス バイオサイエンス インコーポレイテッド | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 |
Non-Patent Citations (1)
Title |
---|
JPN6015047596; Satoshi Shuto, et al.: Chem. Pharm. Bull. Vol.47, No.8, 1999, pp.1188-1192 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5041501B2 (ja) | アミド化合物を配位子とする遷移金属錯体を用いたアルコールの製造方法 | |
JP5984988B2 (ja) | (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法 | |
EP2016053B1 (en) | Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes | |
WO2016042441A1 (en) | A novel process for the preparation of considerably pure silodosin | |
KR20070112196A (ko) | 인돌론 유도체 제조 방법 | |
US10377710B2 (en) | Process for the preparation of considerably pure Silodosin | |
JP6257115B2 (ja) | 3−アルキルチオ−2−ブロモピリジンの製造方法 | |
KR100228328B1 (ko) | (2r)-메틸-4,4,4-트리플루오로부틸아민 또는 이것의 산부가염을 제조하는 방법 | |
TW200538455A (en) | Improved process for the preparation of (ethoxymethyl)-tropane derivatives | |
WO2000061572A1 (en) | Diastereoselective preparation of michael adducts | |
JPH04134055A (ja) | ジアルキルアミノアクリル酸アリルエステル及びその製造方法 | |
JP2005281237A (ja) | 光学活性なフタルイミド誘導体の製造法 | |
TW200806609A (en) | Process for preparing 2-ethynylphenylacetamides | |
JP2003212833A (ja) | 製造中間体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151126 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20151126 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160225 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160525 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160705 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160802 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5984988 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |